Seleniso drug profile
Selinexor () is a nuclear protein transport inhibitor used to treat specific types of hematological tumors, mainly including multiple myeloma (Multiple Myeloma, MM). This type of tumor involves the malignant proliferation of plasma cells in the bone marrow, and selinesol's unique mechanism makes it an innovative drug for the treatment of this disease.
Nucleoproteins play a key role in cells, participating in the regulation of gene expression, cell cycle and other important cellular processes. Correct transport of nuclear proteins is critical for maintaining normal cellular function. In some cancer cells, the activity of nuclear protein XPO1 (Exportin 1) is increased, leading to insufficient accumulation of some key proteins in the nucleus, thus affecting normal cell regulation. The mechanism of action of selinesol is to adjust the transport of nuclear proteins by inhibiting nuclear proteinXPO1, so that the balance of key proteins in the nucleus and cytoplasm can be restored.

Specifically, selinesol binds to the nuclear proteinXPO1, forming a complex that prevents its normal function. This results in the nuclear proteinXPO1 being unable to take some key proteins out of the nucleus, thereby affecting the protein distribution within the cell and inhibiting the growth and proliferation of cancer cells.
Seleniso is already on the market in China and has been included in medical insurance, but its price is quite expensive, about 10,000 to 20,000 yuan, making patients bear higher treatment costs. It is recommended to consult the local hospital pharmacy for specific prices and medical insurance reimbursement status. Different from the domestic market, Seleniso has two options: original drug and generic drug in the foreign market. The original drug is the American version of the original drug. Because of its higher research and development costs, the price is even more expensive, even as high as hundreds of thousands of yuan. In comparison, generic drugs are more affordable. Lao generic drugs are one of the relatively low-priced generic drugs, with prices ranging from 2,000 yuan to 4,000 yuan. Compared with original drugs, they are more affordable. The ingredients of original drugs and generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)